Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer’s disease and tauopathies

Springer Science and Business Media LLC - Tập 8 - Trang 1-2 - 2013
Heike Hering1, Danielle Graham1, Solenne Ousson2, Maud Neny2, Audrey Gray1, Brandy Giacomozzi1, John Joyce1, Vikram Dutt1, Michael Busch3, Andrew Cameron1, Leslie Liu-Bujalski1, Henry Yu1, Hui Tian1, Mark Shearman1, Anna Quattropani2, Bruno Permanne2, Christoph Wiessner2, Dirk Beher2
1EMD Serono Research Institute, Billerica, USA
2Asceneuron SA, Lausanne, Switzerland
3Merck KGaA, Darmstadt, Germany

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 8

1-2

Thông tin tác giả